Prodisc® Total Disc Replacement from Centinel Spine® Grows 38% in Full-Year 2024, Setting a New Revenue Record in the Fourth Quarter
Centinel Spine®, LLC the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced achievement of record fourth quarter and full-year 2024 business results, positioning the Company for continued accelerated growth in 2025.